Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Shareholders of Novorossiysk Bakery Products Plant approved dividends

12/28/23 NKHP

Nornickel conducted four token issues for metals

12/28/23 GMKN

Sovfed proposed to exempt investors from taxes

12/28/23 MOEX

Yandex ICAO was created by the Netherlands-based Yandex N.V.

12/28/23 YNDX

Mosgorlombard raised ₽303 million in its IPO

12/28/23 MGKL

IPO Mosgorlombard went on the bottom line

12/28/23 MGKL

Lenta opens second STM test center

12/28/23 LENT

Irtea is testing Asian smartphones on 5G networks

12/28/23 MTSS

Shareholders of Rosneft Oil Company approved dividends

12/27/23 ROSN

TGC-1 sold 60.5% of Teploseti Saint-Petersburg to St. Petersburg

12/27/23 TGKA